The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationJ. Surg. Res. 2005, 129(1):64-72
AbstractINTRODUCTION: The purpose of this study was to examine the effect of global gene ablation of SSTR5 on the endocrine pancreas, insulin secretion, and glucose tolerance in aging mice, as SSTR5 is a primary regulator of insulin secretion in the mouse pancreas. METHODS: Global SSTR5-/- mice were generated and genotypes were verified using Southern blot and RT-PCR. Glucose tolerance and in vivo insulin secretion in SSTR5-/- and WT mice were examined using intraperitoneal glucose tolerance test (IPGTT;1.2-2.0 mg/kg) at 3 and 12 months of age (n = 8 per group). Basal and glucose-stimulated insulin secretion in vitro was studied using the isolated perfused mouse pancreas model at 3 and 12 months. Pancreata were removed and levels of insulin, glucagon, somatostatin, and SSTR1 were studied using immunohistochemical analysis along with H&E staining of the pancreata. RESULTS: Genotyping verified the absence of SSTR5 in SSTR5-/- mice. IPGTT demonstrated that 3-month-old SSTR5-/- mice were glucose intolerant despite similar insulin secretion both in vivo and in vitro and enlarged islets. At 12 months of age, SSTR5-/- mice had basal hypoglycemia and improved glucose intolerance associated with hyperinsulinemia in vivo and in vitro and enlarged islets. SSTR5-/- mice had increased insulin clearance at 3 and 12 months of age. SSTR1 expression was significantly increased in islets at 3 months of age, but was nearly absent in islets at 12 months of age, as was somatostatin staining in SSTR5-/- mice. CONCLUSIONS: These results suggest that both SSTR5 and SSTR1 play a pivotal role in insulin secretion and glucose regulation in mice and that their regulatory effects are age-related.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field
- Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.
- Authors: Wang XP, Norman MA, Yang J, Cheung A, Moldovan S, Demayo FJ, Brunicardi FC
- Issue date: 2004 Sep
- SSTR5 ablation in islet results in alterations in glucose homeostasis in mice.
- Authors: Wang XP, Yang J, Norman MA, Magnusson J, DeMayo FJ, Brunicardi FC
- Issue date: 2005 Jun 6
- Alterations in glucose homeostasis in SSTR1 gene-ablated mice.
- Authors: Wang XP, Norman M, Yang J, Magnusson J, Kreienkamp HJ, Richter D, DeMayo FJ, Brunicardi FC
- Issue date: 2006 Mar 9
- Pancreatic somatostatin inhibits insulin secretion via SSTR-5 in the isolated perfused mouse pancreas model.
- Authors: Tirone TA, Norman MA, Moldovan S, DeMayo FJ, Wang XP, Brunicardi FC
- Issue date: 2003 Apr
- Sulfonylurea receptor knockout causes glucose intolerance in mice that is not alleviated by concomitant somatostatin subtype receptor 5 knockout.
- Authors: Norman M, Moldovan S, Seghers V, Wang XP, DeMayo FJ, Brunicardi FC
- Issue date: 2002 Jun